ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, AND DOXYLAMINE SUCCINATE and NASOPHARYNGITIS

126 reports of this reaction

3.6% of all ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, AND DOXYLAMINE SUCCINATE reports

#3 most reported adverse reaction

Overview

NASOPHARYNGITIS is the #3 most commonly reported adverse reaction for ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, AND DOXYLAMINE SUCCINATE, manufactured by The Procter & Gamble Manufacturing Company. There are 126 FDA adverse event reports linking ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, AND DOXYLAMINE SUCCINATE to NASOPHARYNGITIS. This represents approximately 3.6% of all 3,480 adverse event reports for this drug.

Patients taking ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, AND DOXYLAMINE SUCCINATE who experience nasopharyngitis should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

NASOPHARYNGITIS126 of 3,480 reports

NASOPHARYNGITIS is moderately reported among ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, AND DOXYLAMINE SUCCINATE users, representing a notable but not dominant share of adverse events.

Other Side Effects of ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, AND DOXYLAMINE SUCCINATE

In addition to nasopharyngitis, the following adverse reactions have been reported for ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, AND DOXYLAMINE SUCCINATE:

Other Drugs Associated with NASOPHARYNGITIS

The following drugs have also been linked to nasopharyngitis in FDA adverse event reports:

ACETAMINOPHEN AND CODEINEACETAMINOPHEN, DEXTROMETHORPHAN HBRACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATEACETAMINOPHEN, DEXTROMETHORPHAN HBR, PHENYLEPHRINE HCLACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, AND PHENYLEPHRINE HYDROCHLORIDEACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATEACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDEACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDEADALIMUMABADRENALINUMAGNUS CASTUSARTHRITIS PAIN RELIEFCAMPHORCHLORHEXIDINE GLUCONATE AND ISOPROPYL ALCOHOLCICLESONIDECOAL TARCOCOA BUTTER, PHENYLEPHRINE HCLDEFLAZACORTDESOGESTREL AND ETHINYL ESTRADIOLDEXTROMETHORPHAN HBR AND GUAIFENESIN

Frequently Asked Questions

Does ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, AND DOXYLAMINE SUCCINATE cause NASOPHARYNGITIS?

NASOPHARYNGITIS has been reported as an adverse event in 126 FDA reports for ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, AND DOXYLAMINE SUCCINATE. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is NASOPHARYNGITIS with ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, AND DOXYLAMINE SUCCINATE?

NASOPHARYNGITIS accounts for approximately 3.6% of all adverse event reports for ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, AND DOXYLAMINE SUCCINATE, making it one of the most commonly reported side effect.

What should I do if I experience NASOPHARYNGITIS while taking ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, AND DOXYLAMINE SUCCINATE?

If you experience nasopharyngitis while taking ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, AND DOXYLAMINE SUCCINATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages

ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, AND DOXYLAMINE SUCCINATE Full ProfileAll Drugs Causing NASOPHARYNGITISThe Procter & Gamble Manufacturing Company Drugs
Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.